Bachemウェビナー：Scalable Oligonucleotide Manufacture With Stirred-Bed Technology

【開催日時】　2023年5月25日（木） 00:00～1:00（60分間）※日本時間

【参加費】　　無料（事前登録制）

【受講方法】　オンライン
下記リンク（”セミナーホームページを見る”）より事前登録をお願い致します。
リンク先にあります Please register hereよりお申し込み頂けます。

【ウェビナー内容】
Based on decades of experience in applying stirred-bed reactors for making peptides, we investigated whether these could be used for the manufacturing of oligonucleotides as well. Join our webinar on scalable oligonucleotide manufacturing with stirred-bed technology (SBT) to learn how we can reach commercial oligonucleotides API production in metric ton range with unbeaten process mass intensity. You will get insights into case studies, our SBT capacities for R&D to large scale production projects, and typical CMC activities for scale-up. Finally, we will share the distinct advantages stirred-bed solid-phase oligonucleotide synthesis (SPOS) has over classical fixed-bed SPOS.

【スピーカー】
Daniel Samson, PH.D., Vice President, Head Oligonucleotides
Daniel brings 15 years of industry experience to the team, with an emphasis on TIDES process R&D, manufacturing and CMC development. He leads Bachem’s oligonucleotide unit including innovation projects, R&D and manufacturing activities. Daniel holds a PhD in organic chemistry from the University of Konstanz, and an MBA from the International Institute for Management Development (IMD), Lausanne. In previous stages of his career he was a lab head for process optimization, technology transfer, Quality by Design, and scale-up of synthetic peptide manufacturing procedures. From 2012, Daniel was a Vice President API Manufacturing and had full responsibility for all large-scale solid phase peptide and oligonucleotide syntheses, downstream operations, and CMC activities within Bachem AG.

• セミナーパンフレットを見る
• セミナーホームページを見る